NEOS Investment Management LLC flexed its biotech muscles by upping its stake in Regeneron Pharmaceuticals by a hearty 30.6% in Q4. The firm now owns 17,650 shares worth a tidy $12.57 million, proving ...
14hon MSN
We recently published a list of 11 Blue Chip Stocks to Invest in at 52-Week Lows. In this article, we are going to take a ...
The equity portion of the Abrdn Healthcare Investors Fund fell (gross of fees) but outperformed its custom benchmark over the ...
With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, industry ...
Buying $1000 In REGN: If an investor had bought $1000 of REGN stock 20 years ago, it would be worth $130,880.12 today based ...
Biotech company Regeneron (REGN) and French pharmaceutical giant Sanofi (SNY) today announced that Japan has granted ...
BOSTON, March 28, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics ...
Regeneron (REGN) and Sanofi (SNY) announced that the Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing ...
Regeneron Pharmaceuticals just belly-flopped into a fresh 12-month low, trading as low as $640.28—Wall Street winced. Analyst ...
Students from Salem High School on March 20 participated in the New Hampshire Science and Engineering Expo held at NHTI, ...
An ʻIolani School senior recently took home a top prize at the nation’s oldest science research competition for high school students. Logan Lee traveled to Washington, D.C., earlier this month for the ...
We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we are going to look at where Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback